TLDR Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.
Male pattern hair loss, or androgenetic alopecia, affects 30-50% of men aged 20-25 and older, significantly impacting their quality of life and mental health. It is linked to various health issues, including skin cancer, cardiovascular diseases, and is heavily influenced by genetics, with heredity contributing 80% to its development. Treatments like minoxidil and finasteride can prevent further hair loss but have limited success in reversing baldness and require continuous use, with potential side effects such as sexual dysfunction and skin irritation. Hair transplantation offers a more lasting solution, achieving desirable results in up to 98% of cases.
May 2024 in “Indian Journal of Dermatology” Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.
49 citations,
January 2021 in “Journal of The European Academy of Dermatology and Venereology” Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.
14 citations,
March 2014 in “Journal of The European Academy of Dermatology and Venereology” Young adults with hair loss face higher risk of stiff arteries.
62 citations,
March 2008 in “American Journal of Human Genetics” Hair loss gene found on chromosome 3q26.
August 2021 in “Pharmacy Today” The document's conclusion about hair loss cannot be determined.
June 2021 in “Elsevier eBooks” The document's conclusion cannot be summarized because it is not readable or understandable.
The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.
